Crossmark

<sup>211</sup>At-labeled immunoconjugate <i>via</i> a one-pot three-component double click strategy: practical access to α-emission cancer radiotherapeutics

Crossref DOI link: https://doi.org/10.1039/C8SC04747B

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Fujiki, Katsumasa

Kanayama, Yousuke

Yano, Shinya

Sato, Nozomi

Yokokita, Takuya

Ahmadi, Peni

Watanabe, Yasuyoshi

Haba, Hiromitsu

Tanaka, Katsunori https://orcid.org/0000-0001-6932-4802
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (JP16H03287)

Japan Society for the Promotion of Science (JP18K19154)

Japan Society for the Promotion of Science (JP17K10382)

Japan Society for the Promotion of Science (JP15H05843)

Japan Agency for Medical Research and Development (JP18am0301006)
License Information

Version of Record valid from 2018-12-21
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Katsunori Tanaka (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 25 October 2018; Accepted 19 December 2018; Accepted Manuscript published 21 December 2018; Advance Article published 4 January 2019; Version of Record published 13 February 2019

Document is current

Any future updates will be listed below